TyraTech acquired by American Vanguard Corp.

TyraTech, Inc., a publicly-traded AIM market life sciences company focused on nature-derived insect and parasite control products, merged with American Vanguard Corp. Prior to the transaction, American Vanguard held approximately 35% of the shares of Tyratech. The transaction included de-listing of Tyratech shares from the AIM market.

Waller served as lead counsel to TyraTech in the transaction.

For additional information, see media coverage here.

Related Experience

North American Partners in Anesthesia (NAPA) acquires American Anesthesiology

Served as legal counsel to North American Partners in Anesthesia (NAPA) in its acquisition of American Anesthesiology, a MEDNAX, Inc. medical group.

HCA to sell Garden Park Medical Center

Serving as special healthcare counsel in the transaction and providing due diligence and regulatory review support.

Summit BHC acquires Peak View Behavioral Health

Represented Summit Behavioral Healthcare in its acquisition of Colorado-based Peak View Behavioral Health.

View More